Seattle’s VerAvanti Raises $31.5M Series A to Develop Stroke-Preventing Imaging Scopes, Plans 2026 Product Launch

Seattle-based VerAvanti raised $31.5 million in Series A funding to develop ultra-thin imaging scopes aimed at preventing strokes and heart attacks, with plans to commercialize the product by early 2026. The company also leased a new manufacturing facility and is progressing toward FDA approval.

GGerald McMorrow UUniversity of Washington